 |
2-amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| EU Market Approval | EU |
| EU Designation Date | 2015-12-14 00:00:00 |
| Sponsor | Novartis Europharm Limited |
